Stella Diagnostics Inc (SLDX)
Stella Diagnostics, Inc. is a common stock listing on OTC Markets under the symbol SLDX. The company is a healthcare diagnostics business focused on developing molecular diagnostic tools and new drug targets for esophageal diseases. Its research centers on the use of targeted mass spectrometry to measure disease progression in tissue from the lower esophagus, with the aim of helping identify patients at higher risk of advancing from disease to precancerous conditions or cancer. The company’s technology is intended to support clinical interpretation for gastroenterologists, surgical oncologists, and pathologists. Formerly known as JMP Properties, Inc., the company adopted the Stella Diagnostics name in April 2021 and is based in Salt Lake City, Utah.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Market Cap |
|---|---|---|---|---|---|---|
|
OTC-SLDX
|
Not available
|
Not available
|
Not available
|
Weak
|
0.0%
|
2.43 M
|